SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-13-334245
Filing Date
2013-08-14
Accepted
2013-08-14 13:21:23
Documents
13
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d540814d10k.htm 10-K 1480415
2 EX-21.1 d540814dex211.htm EX-21.1 6412
3 EX-23.1 d540814dex231.htm EX-23.1 5098
4 EX-31.1 d540814dex311.htm EX-31.1 9123
5 EX-31.2 d540814dex312.htm EX-31.2 9103
6 EX-32 d540814dex32.htm EX-32 3814
13 GRAPHIC g540814g26g59.jpg GRAPHIC 35641
  Complete submission text file 0001193125-13-334245.txt   13466669

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mygn-20130630.xml EX-101.INS 1588912
8 XBRL TAXONOMY EXTENSION SCHEMA mygn-20130630.xsd EX-101.SCH 73908
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20130630_cal.xml EX-101.CAL 115549
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20130630_def.xml EX-101.DEF 433218
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20130630_lab.xml EX-101.LAB 588473
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20130630_pre.xml EX-101.PRE 512219
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26642 | Film No.: 131036631
SIC: 2835 In Vitro & In Vivo Diagnostic Substances